← Browse by Condition
Medical Condition
parkinson disease
Total Trials
9
Recruiting Now
9
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for parkinson disease sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.
- Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
- Phase 1–4 studies from early safety trials to post-marketing surveillance
- NIH, pharmaceutical sponsor, and academic medical center studies worldwide
- AI-powered plain-language summary available for every trial listing
Frequently Asked Questions — parkinson disease Clinical Trials
How many clinical trials are currently recruiting for parkinson disease?
ClinicalMetric currently tracks 9 actively recruiting clinical trials for parkinson disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 9. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for parkinson disease?
parkinson disease research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a parkinson disease clinical trial?
Eligibility criteria for parkinson disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT04957095
Recruiting
Motor Network Physiology
Enrollment
120 pts
Location
United States
Sponsor
University of Texas Southweste...
NCT06479083
Recruiting
Interdisciplinary + Intersectoral Telemedicine Evaluation, Coordination + Treatment in RhineMain+ Parkinson's Network
Enrollment
1,354 pts
Location
Germany
Sponsor
Johannes Gutenberg University ...
NCT06852352
Recruiting
An Exploratory Study to Confirm Efficacy of Modified Deep Cervical Lymphovenous Anastomosis (LVA) in Alzheimer's Disease/ Parkinson's Disease
Enrollment
160 pts
Location
China
Sponsor
Zhejiang Provincial People's H...
NCT06062693
Recruiting
New Interactive Sensor-home-based Hand Training to Improve Dexterity
Enrollment
160 pts
Location
Switzerland
Sponsor
Luzerner Kantonsspital
NCT06453226
Recruiting
Non-invasive Detection of Volatile Metabolites in Parkinson's Disease
Enrollment
120 pts
Location
United Kingdom
Sponsor
Imperial College London
NCT05094219
Recruiting
Disease Burden and Cost Consequence of Falls Among Individuals With Parkinson's Disease in Hong Kong: A Prospective Cost-utility Analysis
Enrollment
90 pts
Location
Hong Kong
Sponsor
The Hong Kong Polytechnic Univ...
NCT05981261
Recruiting
Experimental Pain in Parkinsons
Enrollment
63 pts
Location
Denmark
Sponsor
University of Aarhus
NCT06052280
Recruiting
Pilot Study: Parkinson's Conventional Physiotherapy vs Home-based Telerehabilitation
Enrollment
40 pts
Location
Italy
Sponsor
Azienda Sanitaria Locale CN1 C...
NCT03025334
Recruiting
tDCS on Parkinson's Disease Cognition
Enrollment
36 pts
Location
Canada
Sponsor
University of Manitoba
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology